In WT hearts, treatment induced a small significant reduction in LVIDs, a nonsignificant trend in increased ejection fraction, and no appreciable changes in LVIDd.
← all excerpts
Glucocorticoid chronopharmacology promotes glucose metabolism in heart through a cardiomyocyte-autonomous transactivation program.
1
—
—